Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

Immunotherapies have emerged as one of the most promising approaches to treat patients with cancer. Recently, there have been many clinical successes using checkpoint receptor blockade, including T cell inhibitory receptors such as cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Masucci, Giuseppe V., Cesano, Alessandra, Hawtin, Rachael, Janetzki, Sylvia, Zhang, Jenny, Kirsch, Ilan, Dobbin, Kevin K., Alvarez, John, Robbins, Paul B., Selvan, Senthamil R., Streicher, Howard Z., Butterfield, Lisa H., Thurin, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109744/
https://www.ncbi.nlm.nih.gov/pubmed/27895917
http://dx.doi.org/10.1186/s40425-016-0178-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109744/
https://www.ncbi.nlm.nih.gov/pubmed/27895917
http://dx.doi.org/10.1186/s40425-016-0178-1

Ejemplares similares